G.G. Steger
Impact in
-
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 27
- Cancer Treatment and Pharmacology 17
- HER2/EGFR in Cancer Research 9
- Bone health and treatments 3
-
- Advanced Breast Cancer Therapies 12
- Brain Metastases and Treatment 2
- Co-authors
- Michael Gnant (21 shared papers)M. Médici (1 shared paper)Alessandra Fabi (1 shared paper)Fausto Roila (1 shared paper)Cornelia Bachmann (1 shared paper)Franco Nolè (1 shared paper)Matti Aapro (1 shared paper)R. Jakesz (11 shared papers)
- Journals
- European Journal of Cancer (9 papers)Cancer Research (8 papers)The Breast (4 papers)British Journal of Cancer (3 papers)Annals of Oncology (2 papers)
- Partner nations
- AustriaUnited StatesSpain
In The Last Decade
G.G. Steger
38 papers receiving 401 citations
Peers
Comparison fields: 5 of 48
- Oncology 122
- Cancer Research 64
- Surgery 163
- Dermatology 24
- Genetics 77
Countries citing papers authored by G.G. Steger
This map shows the geographic impact of G.G. Steger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.G. Steger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.G. Steger more than expected).
Fields of papers citing papers by G.G. Steger
This network shows the impact of papers produced by G.G. Steger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.G. Steger. The network helps show where G.G. Steger may publish in the future.
Co-authors
The 25 scholars most cited alongside G.G. Steger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 116 | |
| 2 | 1999 | 46 | |
| 3 | 2013 | 42 | |
| 4 | 1998 | 40 | |
| 5 | 2005 | 33 | |
| 6 | 1995 | 21 | |
| 7 | Karyotype and prognosis in non-Hodgkin lymphoma. | 1994 | 17 |
| 8 | 2011 | 13 | |
| 9 | 1993 | 11 | |
| 10 | 2009 | 10 | |
| 11 | Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2. | 2000 | 8 |
| 12 | 1998 | 8 | |
| 13 | 2017 | 7 | |
| 14 | 2011 | 5 | |
| 15 | 2010 | 3 | |
| 16 | 2004 | 3 | |
| 17 | 2017 | 2 | |
| 18 | 2009 | 2 | |
| 19 | 2003 | 2 | |
| 20 | Phase II trial of recombinant interferon alpha-2C in metastatic renal cell carcinoma. | 1988 | 2 |
About G.G. Steger
G.G. Steger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 40 papers that have together received 415 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (17 papers), Advanced Breast Cancer Therapies (12 papers), Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (9 papers), Estrogen and related hormone effects (5 papers), Bone health and treatments (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Oncology (122 citations), Cancer Research (64 citations), Surgery (163 citations), Dermatology (24 citations) and Genetics (77 citations). G.G. Steger has collaborated with scholars based in Austria, United States and Spain. Frequent co-authors include Michael Gnant, M. Médici, Alessandra Fabi, Fausto Roila, Cornelia Bachmann, Franco Nolè, Matti Aapro, R. Jakesz, Rupert Bartsch and Heinz Pflüger. Their work appears in journals such as European Journal of Cancer, Cancer Research, The Breast, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.